Concepedia

Matthew Peloquin

MP

8

Publications

696

Citations

8

H-Index

2016

Active since

Affiliations

Pfizer (United States)(Current)

Sanford Burnham Prebys Medical Discovery Institute

Discovery Institute

University of Debrecen

Matthew Peloquin is an author at Pfizer (United States) specializing in medicine, cell signaling, and oxidative stress.

ORCID

Top concepts

Publications per year

2016–2022

8

Publications

8

The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages

Zsolt Czimmerer, Bence Dániel, Attila Horváth et al. · Immunity · 2018 · 234 citations · Full text

Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration

Tamás Varga, Rémi Mounier, Andreas Patsalos et al. · Immunity · 2016 · 175 citations · Full text

, , +10

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models

Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore et al. · EBioMedicine · 2018 · 146 citations · Full text

In vivo GDF3 administration abrogates aging related muscle regeneration delay following acute sterile injury

Andreas Patsalos, Zoltán Simándi, Tristan T. Hays et al. · Aging Cell · 2018 · 38 citations · Full text

BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice

Eliza Bollinger, Matthew Peloquin, Jenna Libera et al. · Molecular Metabolism · 2022 · 36 citations · Full text

Rows per page

1–5 of 8